Positive Results From A Trial Lift Adverum (ADVM) Stock Today
Pre-market trading saw a notable spike in the shares of Adverum Biotechnologies, Inc. (NASDAQ: ADVM). Adverum stock saw a 6.76% climb to $3.00, carrying on the momentum from the previous session when it experienced a 12.40% jump, finishing at $2.81. The excellent results of a clinical study are responsible for this rising trend and the […]
